Alghanem, S S <br/><br/>
Pharmacokinetic/pharmacodynamic analysis of weight- and height-scaled tobramycin dosage regimens for patients with cystic fibrosis.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  08 2019 
 - 2311-2317 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2091 
<br/><br/><label>Standard No.: </label>10.1093/jac/dkz192  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--administration & dosage<br/>Body Height<br/>Body Weight<br/>Cystic Fibrosis--complications<br/>Female<br/>Humans<br/>Male<br/>Microbial Sensitivity Tests<br/>Middle Aged<br/>Models, Statistical<br/>Plasma--chemistry<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa--drug effects<br/>Tobramycin--administration & dosage<br/>Young Adult